Magnetar Financial LLC - EUCRATES BIOMEDICAL ACQU COR ownership

EUCRATES BIOMEDICAL ACQU COR's ticker is EUCRU and the CUSIP is G3141W114. A total of 14 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Magnetar Financial LLC ownership history of EUCRATES BIOMEDICAL ACQU COR
ValueSharesWeighting
Q2 2022$3,930,000
-11.6%
392,001
-12.9%
0.04%
-12.8%
Q1 2022$4,446,000
-1.2%
450,000
-0.1%
0.05%
+4.4%
Q4 2021$4,498,000
-0.6%
450,657
-0.9%
0.04%
-2.2%
Q3 2021$4,526,000
-2.3%
454,6570.0%0.05%
+4.5%
Q2 2021$4,633,000
+2.0%
454,657
+1.0%
0.04%0.0%
Q1 2021$4,541,000
-13.6%
450,000
-10.0%
0.04%
-40.5%
Q4 2020$5,255,000500,0000.07%
Other shareholders
EUCRATES BIOMEDICAL ACQU COR shareholders Q3 2022
NameSharesValueWeighting ↓
Sio Capital Management, LLC 248,674$2,452,0000.81%
Wealthspring Capital LLC 138,373$1,365,0000.27%
Cowen Investment Management LLC 100,000$986,0000.21%
Integrity Capital Management (HK) Ltd 3,800$37,0000.19%
Sage Mountain Advisors LLC 94,640$933,0000.15%
Schechter Investment Advisors, LLC 82,802$816,0000.08%
Verition Fund Management LLC 397,603$3,928,0000.05%
Magnetar Financial LLC 450,000$4,446,0000.05%
HGC Investment Management Inc. 79,150$781,0000.05%
RIVERNORTH CAPITAL MANAGEMENT, LLC 75,650$747,0000.03%
View complete list of EUCRATES BIOMEDICAL ACQU COR shareholders